Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 April, 2017 13:21 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Reliance Home Finance FY17 net jumps 2-fold to Rs 1.73 bn - 26-Apr-2017 12:17
LIC Housing Finance quarterly profit rises 18% - 26-Apr-2017 11:55
Nucleus Software Exports quarterly profit jumps 57.66% - 26-Apr-2017 11:42
Adani Ports form JV with France's CMA CGM - 26-Apr-2017 11:28
Kolte Patil signs redevelopment project in Mumbai - 26-Apr-2017 11:21
NIIT Tech enters into partnership with SCCC - 26-Apr-2017 11:17
Persistent Systems quarterly earnings drop 0.41% - 26-Apr-2017 10:51
M&M's arm acquires 100% stake in MANA - 26-Apr-2017 10:34
Persistent Systems enters into strategic collaboration with Partners HealthCare - 26-Apr-2017 09:50
Zensar Technologies quarterly earnings plunges 84.49% - 26-Apr-2017 09:11
Wipro Q4 profit rises 7% on sequential basis to Rs 22.67 bn - 25-Apr-2017 17:02
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer